Related Experiment Video
Updated: Aug 1, 2025
The Hypoxic Ischemic Encephalopathy Model of Perinatal Ischemia
Published on: November 19, 2008
Chloroquine Protects Hypoxia/Ischemia-Induced Neonatal Brain Injury in Rats by Mitigating Blood-Brain Barrier
Mingchu Fang1,2,3,4,5, Jian Liu6, Zhiwei Zhang2
1Department of Neonatology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325027, China.
Insights
Chloroquine (CQ) protects the neonatal brain from hypoxic-ischemic (H/I) brain damage (HIBD) by maintaining blood-brain barrier (BBB) integrity. This neuroprotective effect reduces brain injury and improves neurological function in newborns.
Area of Science:
- Neuroscience
- Pharmacology
- Neonatal Medicine
Background:
- Neonatal hypoxic-ischemic brain damage (HIBD) causes severe neurological deficits with no effective treatments.
- Blood-brain barrier (BBB) compromise is a key factor in HIBD-induced neuronal cell death and secondary brain injury.
Purpose of the Study:
- To investigate the neuroprotective potential of chloroquine (CQ) in a neonatal rat model of HIBD.
- To determine if CQ protects the BBB from H/I insult and improves neurofunctional outcomes.
Main Methods:
- Utilized the Rice-Vannucci rat model to induce HIBD in neonatal rats.
- Administered CQ and evaluated its effects on brain damage, BBB integrity, and behavioral outcomes.
- Assessed BBB integrity through measurements of brain edema, Evans blue extravasation, tight junction/adherens junction protein expression, and pericyte survival.
Main Results:
- CQ administration significantly reduced brain damage and improved behavioral deficits following H/I injury.
- CQ treatment preserved BBB integrity by decreasing brain edema and Evans blue leakage.
- CQ inhibited the degradation of tight junction and adherens junction proteins and enhanced pericyte survival.
Conclusions:
- CQ demonstrates significant neuroprotective effects in neonatal HIBD by safeguarding BBB integrity.
- CQ ameliorates brain damage and promotes neurofunctional recovery in neonatal rats subjected to H/I injury.
- CQ shows promise as a therapeutic agent for treating HIBD by targeting BBB protection.
Abstract:
Neonatal hypoxic-ischemic (H/I) brain damage (HIBD) is a devastating condition for which there are presently no effective therapeutic strategies against its severe neurological deficits in neonates and young children. Traditionally, H/I induces the compromise of the blood-brain barrier (BBB), which causes neuronal cell death, eventually resulting in brain secondary injury. In addition to neonatal HIBD, chloroquine (CQ) has been proved to exert a protective effect on BBB disruption in several brain injury models. The main purpose of this research was to study whether CQ protects the BBB from H/I insult and confers beneficial neuroprotection in the neonatal Rice-Vannucci rat model. Herein, we reported that CQ administration significantly reduced brain damage and improved behavioral dysplasia after H/I injury. Moreover, we demonstrated the protective effects of CQ on BBB integrity, evidenced by ameliorating brain edema and Evans blue extravasation, inhibiting the degeneration of the tight junction and adherens junction proteins, and improving pericyte survival in neonatal rats after HIBD. These findings indicated that CQ administration protected the BBB against H/I injury, thereby ameliorating brain damage and promoting neurofunctional recovery. Collectively, our data demonstrated that CQ played a crucial role in BBB integrity after neonatal H/I injury, which sheds light on the development of therapeutic agents to treat HIBD.
More Related Videos
05:52Early Pathological and Magnetic Resonance Detection of Cerebral Injury Using a Rat Model of Neonatal Hypoxic Ischemic Encephalopathy
Published on: October 28, 2022
07:36Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015